Breaking News

Akrimax Enters Manufacturing Pact

Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009. 
    
Akrimax president Alan L. Rubino commented, “This agreement further validates Akrimax’s decision to acquire the [Wyeth] Rouses Point facility, which possesses diverse manufacturing and packaging capabilities, and a spotless regulatory and safety record. We are pleased to announce this development as we are ahead of our planned schedule of bringing in new manufacturing partnerships to our Rouses Point facility.”

Akrimax is a specialty pharma company focusing on metabolic syndrome treatments. The company also has a contract manufacturing division.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters